Doliente, Luzviminda B.

HRN: 00-57-44  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/28/2024
CEFIXIME 200MG (CAP)
08/28/2024
09/04/2024
PO
200mg
Q12
CAP MR
Waiting Final Action 

Indication:  Empirical De-escalation    Type of Infection:  Urinary TractPneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: